# A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

> **NCT07654751** · PHASE4 · RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 10 (estimated)

## Conditions studied

- Psoriasis
- Colitis, Ulcerative
- Crohn Disease
- Arthritis, Psoriatic

## Interventions

- **PROCEDURE:** Breast Milk Sample Collection
- **DRUG:** Guselkumab

## Key facts

- **NCT ID:** NCT07654751
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-07
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07654751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07654751, "A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07654751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*